Trial Profile
Phase I trial of SAR 113244, an anti-CXCR5 monoclonal antibody, in patients with systemic lupus erythematosus.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2012
Price :
$35
*
At a glance
- Drugs SAR-113244 (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions
- 30 Oct 2012 Profile title is not an official study title
- 30 Oct 2012 New trial record